Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Synaptophysin is a presynaptic vesicle protein and a marker of synaptic density. We have studied the expression of its encoding mRNA in the brains of rats treated with haloperidol (2 mg kg-1 d-1) for two weeks. A significant increase in synaptophysin mRNA content was observed in the dorsolateral striatum but not in other brain areas compared with control animals. A similar trend was observed for synaptophysin immunoreactivity. Quantification of synaptophysin mRNA per cell showed that the increase was pronounced in large putatively cholinergic, striatal neurones. These data provide further evidence that localized synaptic plasticity occurs after neuroleptic treatment and indicate that such alterations are manifested in terms of expression of a synaptic protein gene by striatal neurones.

Original publication

DOI

10.1097/00001756-199402000-00004

Type

Journal article

Journal

Neuroreport

Publication Date

24/02/1994

Volume

5

Pages

677 - 680

Keywords

Animals, Autoradiography, Frontal Lobe, Gene Expression, Haloperidol, Histocytochemistry, In Situ Hybridization, Male, Neostriatum, Neuronal Plasticity, Nucleus Accumbens, RNA, Messenger, Rats, Rats, Sprague-Dawley, Synapses, Synaptophysin